Needham & Company Downgrades Camtek (CAMT) to Hold

Needham & Company downgraded Camtek (NASDAQ: CAMT) from Buy to Hold amid the recent run.

Analyst Y. Edwin Mok said while they expect the growth trend to continue into 2H17, they expect to see some deceleration as large orders for back-end semi inspections materialize and the PCB business normalizes.

Mok said the stock does not look expensive at a CY2018 ex-cash P/E of 12x, but historically it has carried a low multiple due to uncertainty around the Gryphon inkjet solder mask efforts.

For an analyst ratings summary and ratings history on Camtek click here. For more ratings news on Camtek click here.

Shares of Camtek closed at $5.91 yesterday.

You May Also Be Interested In

• UPDATE: Needham & Company Downgrades Verrica Pharmaceuticals (VRCA) to Hold
• UPDATE: Piper Sandler Downgrades 2U, Inc. (TWOU) to Underweight, 'Regulatory Overhang Elevates Downside Risk'
• Beijing Capital International Airport (694:HK) PT Lowered to HK$7.30 at JPMorgan